open access
....Delivering definitive change, however, will require more than
positive statements and good intentions. The first quantitative data
demonstrating publication bias in clinical trials—and clear call for
trial registries—was published in 1986 [6].
Anyone withholding the methods and results of a clinical trial is
already in breach of multiple codes and regulations, including the
Declaration of Helsinki, various promises from industry and professional
bodies, and, in many cases, the United States Food and Drug
Administration (FDA) Amendment Act of 2007. Indeed, a recently published
cohort study of trials in clinicaltrials.gov found that more than half
had failed to post results; and even though the FDA is entitled to issue
fines of $10,000 a day for transgressions, no such fines have ever been
levied [3].
In
the face of such slow progress, this commentary sets out some practical
suggestions for auditing, performance tables, accountability, codes of
conduct, and better data that should help to drive up standards and
prevent trial reports being withheld from those who need them most......
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.